AI in Oncology: From Promise to Clinical Integration
Patients, Clinicians, Scientists
The Translational Research Centre in Onco-Hematology (CRTOH), coordinated by Professors Mikael Pittet and Olivier Michielin, is dedicated to promoting translational and interdisciplinary cancer research that has the potential to quickly benefit patients. This involves a close collaboration between clinicians and researchers, and a proximity with the patients. The Centre also aims to promote the training of the next generation of researchers and clinicians focusing on translational cancer research.
The CRTOH comprises 34 research groups and more than 300 collaborators. Our ongoing research efforts are centered around several key areas, including tumor immunology and immunotherapy, precision oncology, cell division and cancer, and cancer pharmacology.
Latest News
An unprecedented view of the immune system’s killer cells
Camilla Jandus is awarded the Robert Wenner Prize
Rethinking ovarian cancer III: the past decade and future directions
The Tumor Hacker: How Data & AI Are Rewriting the Future of Oncology
Professor Olivier Michielin Discusses mRNA Advances in Le Temps
Upcoming event